Division of Biochemistry and Biotechnology, Department of Biosciences, University of Helsinki, Helsinki, Finland.
Institute of Biotechnology, University of Helsinki, Helsinki, Finland.
J Extracell Vesicles. 2014 Aug 6;3. doi: 10.3402/jev.v3.24692. eCollection 2014.
Platelet-derived extracellular vesicles (EVs) participate, for example, in haemostasis, immunity and development. Most studies of platelet EVs have targeted microparticles, whereas exosomes and EV characterization under various conditions have been less analyzed. Studies have been hampered by the difficulty in obtaining EVs free from contaminating cells and platelet remnants. Therefore, we optimized an EV isolation protocol and compared the quantity and protein content of EVs induced by different agonists.
Platelets isolated with iodixanol gradient were activated by thrombin and collagen, lipopolysaccharide (LPS) or Ca(2+) ionophore. Microparticles and exosomes were isolated by differential centrifugations. EVs were quantitated by nanoparticle tracking analysis (NTA) and total protein. Size distributions were determined by NTA and electron microscopy. Proteomics was used to characterize the differentially induced EVs.
The main EV populations were 100-250 nm and over 90% were <500 nm irrespective of the activation. However, activation pathways differentially regulated the quantity and the quality of EVs, which also formed constitutively. Thrombogenic activation was the most potent physiological EV-generator. LPS was a weak inducer of EVs, which had a selective protein content from the thrombogenic EVs. Ca(2+) ionophore generated a large population of protein-poor and unselectively packed EVs. By proteomic analysis, EVs were highly heterogeneous after the different activations and between the vesicle subpopulations.
Although platelets constitutively release EVs, vesiculation can be increased, and the activation pathway determines the number and the cargo of the formed EVs. These activation-dependent variations render the use of protein content in sample normalization invalid. Since most platelet EVs are 100-250 nm, only a fraction has been analyzed by previously used methods, for example, flow cytometry. As the EV subpopulations could not be distinguished and large vesicle populations may be lost by differential centrifugation, novel methods are required for the isolation and the differentiation of all EVs.
血小板衍生的细胞外囊泡(EVs)参与止血、免疫和发育等过程。大多数血小板 EVs 的研究都集中在微颗粒上,而对不同条件下的外体和 EV 特征的分析较少。由于难以获得无细胞和血小板残体污染的 EVs,因此研究受到了阻碍。因此,我们优化了 EV 分离方案,并比较了不同激动剂诱导的 EV 的数量和蛋白含量。
使用碘克沙醇梯度分离的血小板被凝血酶和胶原蛋白、脂多糖(LPS)或钙离子载体激活。通过差速离心分离微颗粒和外体。通过纳米颗粒跟踪分析(NTA)和总蛋白定量 EVs。通过 NTA 和电子显微镜确定粒径分布。蛋白质组学用于表征差异诱导的 EVs。
主要 EV 群体为 100-250nm,超过 90%的 EVs<500nm,无论激活方式如何。然而,激活途径差异调节 EV 的数量和质量,这些 EV 也构成了组成性的 EV。血栓形成激活是最有效的生理 EV 生成器。LPS 是 EV 的弱诱导剂,其蛋白含量与血栓形成的 EV 不同。钙离子载体产生大量蛋白含量低且无选择性包装的 EV。通过蛋白质组学分析,不同激活后和囊泡亚群之间 EV 高度异质。
尽管血小板组成性释放 EVs,但囊泡形成可以增加,激活途径决定形成的 EVs 的数量和货物。这些激活依赖性的变化使得使用样品归一化的蛋白含量无效。由于大多数血小板 EVs 的直径为 100-250nm,因此以前使用的方法(例如流式细胞术)仅分析了一部分 EVs。由于无法区分 EV 亚群,并且差速离心可能会丢失大的囊泡群体,因此需要新的方法来分离和区分所有 EVs。